JP2015517524A5 - - Google Patents

Download PDF

Info

Publication number
JP2015517524A5
JP2015517524A5 JP2015512752A JP2015512752A JP2015517524A5 JP 2015517524 A5 JP2015517524 A5 JP 2015517524A5 JP 2015512752 A JP2015512752 A JP 2015512752A JP 2015512752 A JP2015512752 A JP 2015512752A JP 2015517524 A5 JP2015517524 A5 JP 2015517524A5
Authority
JP
Japan
Prior art keywords
composition
salt
crystalline
methyl
monomesylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015512752A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015517524A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/040933 external-priority patent/WO2013173326A1/en
Publication of JP2015517524A publication Critical patent/JP2015517524A/ja
Publication of JP2015517524A5 publication Critical patent/JP2015517524A5/ja
Pending legal-status Critical Current

Links

JP2015512752A 2012-05-14 2013-05-14 (4S,4aS,5aR,12aS)−4−ジメチルアミノ−3,10,12,12a−テトラヒドロキシ−7−[(メトキシ(メチル)アミノ)−メチル]−1,11−ジオキソ−1,4,4a,5,5a,6,11,12a−オクタヒドロ−ナフタセン−2−カルボン酸アミドの使用方法 Pending JP2015517524A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261646754P 2012-05-14 2012-05-14
US61/646,754 2012-05-14
PCT/US2013/040933 WO2013173326A1 (en) 2012-05-14 2013-05-14 Methods of using (4s,4as,5ar,12as)-4- dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide

Publications (2)

Publication Number Publication Date
JP2015517524A JP2015517524A (ja) 2015-06-22
JP2015517524A5 true JP2015517524A5 (https=) 2016-06-30

Family

ID=49548796

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015512752A Pending JP2015517524A (ja) 2012-05-14 2013-05-14 (4S,4aS,5aR,12aS)−4−ジメチルアミノ−3,10,12,12a−テトラヒドロキシ−7−[(メトキシ(メチル)アミノ)−メチル]−1,11−ジオキソ−1,4,4a,5,5a,6,11,12a−オクタヒドロ−ナフタセン−2−カルボン酸アミドの使用方法

Country Status (6)

Country Link
US (1) US20130302442A1 (https=)
EP (1) EP2849757A4 (https=)
JP (1) JP2015517524A (https=)
AU (1) AU2013262991A1 (https=)
CA (1) CA2873412A1 (https=)
WO (1) WO2013173326A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9255068B2 (en) * 2011-05-12 2016-02-09 Warner Chilcott Company, Llc Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the same
AU2016235151A1 (en) * 2015-03-24 2017-10-12 Paratek Pharmaceuticals, Inc. Minocycline compounds for biodefense
AU2019248350B2 (en) * 2018-04-06 2023-07-27 Almirall, Llc Process for making sarecycline hydrochloride

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0375068A1 (en) * 1988-12-23 1990-06-27 Gist-Brocades N.V. Combining bismuth compounds and tetracyclines
JP2007524693A (ja) * 2004-02-20 2007-08-30 ザ バーナム インスティチュート 抗菌性の糖質及びそれを用いた方法
WO2008079339A2 (en) * 2006-12-21 2008-07-03 Paratek Pharmaceuticals, Inc. Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
CA2892739A1 (en) * 2006-12-21 2008-07-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
NO2470500T3 (https=) * 2009-08-28 2018-03-03
WO2012021829A1 (en) * 2010-08-12 2012-02-16 Tetraphase Pharmaceuticals, Inc. Methods of treating bacterial infections
US9255068B2 (en) * 2011-05-12 2016-02-09 Warner Chilcott Company, Llc Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the same

Similar Documents

Publication Publication Date Title
ES2634490T3 (es) Derivados de ácido napht-2-ylacetico para tratar el sida
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
WO2015024010A3 (en) Substituted hydroxamic acid compounds
MX385731B (es) Compuestos de biaril-monobactam y métodos de uso de los mismos para el tratamiento de infecciones bacterianas.
JP2014520077A5 (https=)
AR107864A1 (es) ÁCIDO 7a,11b-DIHIDROXI-6a-ETIL-5b-COLAN-24-OICO Y COMPOSICIONES FARMACÉUTICAS
EA201790345A1 (ru) Применение галогенированных салициланилидов в качестве антибактериальных средств
IL231358A (en) Topical veterinary compositions comprising an isoxazoline active agent for treating or preventing parasitic infection or infestation
ME02558B (me) Inhibitori replikacije virusa gripa
CL2014000468A1 (es) Compuestos derivados del acido 2-oxo-6-(fenil/heteroaril)l-1,2-dihidropiridin-3-carboxilico; composicion farmaceutica; combinacion; y su uso para el alivio de una infeccion bacteriana.
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
JP2015532923A5 (https=)
CL2014001154A1 (es) Compuestos derivados antibioticos de 2-oxo-oxazolidin-3,5-diilo de formula i; composicion farmaceutica; uso para la prevencion o tratamiento de una infeccion bacteriana.
GEP20186857B (en) Saturated nitrogen and n-acylated heterocycles potentiating the activity of an active antibiotic against mycobacteria
CU20150066A7 (es) Compuestos tricíclicos para inhibir el canal cftr
MX2017005422A (es) Inhibidores de histona desacetilasa y sus usos en terapia.
NZ740051A (en) Tetracycline compounds
BR112018074985A2 (pt) composições antibacterianas
WO2009120389A8 (en) Oral and injectable formulations of tetracycline compounds
AR095032A1 (es) Formulaciones de compuestos orgánicos, composición farmacéutica sólida comprimida por rodillo
JP2015517524A5 (https=)
EP4038062A4 (en) N-(1H-IMIDAZOL-2-YL)BENZAMIDE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING IT AS ACTIVE INGREDIENT
WO2015024016A3 (en) 2-piperidinyl substituted n,3-dihydroxybutanamides
HRP20161135T1 (hr) Oblici u krutom stanju n-((s)-2,3-dihidroksi-propil)-3-(2-fluoro-4-jodo-fenilamino)-izonikotinamida
DOP2013000206A (es) Inhibidores de la peptido desformilasa